Male lupus: Retrospective analysis of the clinical and laboratory features of 52 patients, with a review of the literature

Seminars in Arthritis and Rheumatism

Volumn 18, Issue 3, 1989, Pages 189-197

  Kaufman, Lee D ^a   Gomez Reino, J J ^b   Heinicke, Mark H ^c   Gorevic, Peter D ^a  

^a STONY BROOK UNIVERSITY   (United States)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^c UNIVERSITY OF LOUISVILLE   (United States)

Author keywords

male lupus; Systemic lupus erythematosus

Indexed keywords

AUTOANTIBODY;

AGE; CELLULAR IMMUNITY; HISTOLOGY; HUMAN; HUMORAL IMMUNITY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA;

ADOLESCENT; ADULT; AGED; ANIMAL; CHILD; FEMALE; HUMAN; IMMUNITY, CELLULAR; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGE; RETROSPECTIVE STUDIES; SEX FACTORS; SEX HORMONES;

EID: 0024581151     PISSN: 00490172     EISSN: None     Source Type: Journal    
DOI: 10.1016/0049-0172(89)90061-9     Document Type: Article

References (87)

1. Rescherches experimentales sur un rapport probable entre la function du thymus et celle des testicules
2. Sex hormones immune responses and autoimmune diseases Mechanisms of sex hormone action
3. Sex and age in systemic lupus erythematosus
4. Bericht uber acht falle von lupus erythematodes acutus
5. Lupus erythematosus as a systemic disease
6. A diffuse disease of the peripheral circulation (usually associated with lupus erythematosis and endocarditis)
7. Systemic lupus erythematosus: Review of the literature and analysis of 138 cases
8. Preliminary criteria for the classification of systemic lupus erythematosus
9. Systemic lupus erythematosus in males
10. Systemic lupus erythematosus in 49 Israeli males: Retrospective study
11. The 1982 revised criteria for the classification of systemic lupus erythematosus
12. Current approach to systemic lupus erythematosus and its subsets
13. The natural history of systemic lupus erythematosus by prospective analysis
14. Antinuclear antibodies in the investigation of rheumatic diseases
15. Sex effects in systemic lupus erythematosus: A clue to pathogenesis
16. Neonatal lupus erythematosus. A clinical, serological, and immunegenetic study with review of the literature
17. Clinical features of SLE: Differences related to race and age of onset
18. Age influences the clinical and serologic expression of systemic lupus erythematosus
19. Subacute cutaneous lupus erythematosus
20. Studies in familial systemic lupus erythematosus
21. Serologic findings in patients with ANA-negative systemic lupus erythe-matosus
22. Hydrala-zine-induced systemic lupus erythematosus: Influence of HLA-DR and sex on susceptibility
23. Procain-amide-induced lupus erythematosus. Clinical and laboratory observations
24. Progr Allergy
25. Lupus diseases associated with hereditary and acquired deficiencies of complement
26. Hereditary angioedema: The clinical syndrome and its management
27. Chronic cutaneous lupus erythemtosus (DLE)—A clinical and laboratory investigation of 80 patients
28. Prognosis in cutaneous lupus erythematosus
29. Systemic lupus erythe-matosus after “idiopathic” thrombocytopenic purpura A review
30. Adult idiopathic thrombocytopenic purpura: Clinical findings and response to therapy
31. Lupus erythematosus (erythe-matoides) and ovarian function Observations on a possible relationship with report of six cases
32. Problems associated with the management of pregnancies in patients with systemic lupus erythematosus
33. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus
34. The use of testosterone in chronic lupus erythematosus: Preliminary report
35. Hormonal modulation in systemic lupus erythematosus: preliminary clinical and hormonal results with cyproterone acetate
36. Preliminary observations on danazol therapy of systemic lupus erythematosus: Effects on DNA antibodies, thrombocytopenia and complement
37. Systemic lupus erythematosus associated with Klinefelter's syndrome
38. Effect of castration and sex hormone treatment on survival, antinucleic acid antibodies, and glomerulonephritis in NZB X NZW F1 mice
39. Delayed androgen treatment prolongs survival in murine lupus
40. Effect of castration and sex hormones on immune clearance and autoimmune disease in MRL/Mp-1pr/1pr and MRL/mp- +/+ mice
41. Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains
42. Genetics of human and murine lupus erythematosus, in Steinberg AD (moderator): Systemic lupus erythematosus: insights from animal models
43. The effect of gonadectomy on the sex related expression of autoimmune thyroiditis in thymectomized and irradiated rats
44. Beneficial effects of testosterone in the treatment of chronic autoimmune thyroiditis in rats
45. Sex hormonal effects on the severity of streptococcal cell wall induced polyarthritis in the rat
46. Alterations of estrogen metabolism in systemic lupus erythematosus
47. Systemic lupus erythematosus in men: Genetic and endocrine factors
48. Low plasma androgens in women with active or quiescent systemic lupus erythematosus
49. Increased oxidation of testosterone in systemic lupus erythematosus
50. Androgenic status of males with systemic lupus erythematosus
51. Klinefelter's syndrome: Hormone metabolism in hypogonadal males with systemic lupus erythematosus
52. Determination of 16 alpha-hydroxyestrone by radioimmunoassay in systemic lupus erythematosus
53. Systemic lupus erythematosus: Two patients treated with danazol
54. Danazol in systemic lupus erythematosus: A two years prospective controlled trial in forty female patients
55. Hormonal manipulation of the immune response in systemic lupus erythematosus: A drug trial of an anabolic steroid, 19-nortestosterone
56. Treatment of systemic lupus erythematosus (SLE) with the androgen 19-nortestosterone (nandrolone)
57. Interactions between the gonadal steroids and the immune system
58. Effects of short term administration of sex hormones on normal and autoimmune mice
59. Interleukin 2, T cell receptor, and sex hormone studies in autoimmune mice
60. The “Ly-1 B” cell subpopulation in normal, immunodefective, and autoimmune mice
61. Review: The role of the thymus-hypothalamus-pituitary-gonadal axis in normal immune processes and autoimmunity
62. Prolactin receptors on human T and B lymphocytes: Antagonism of prolactin bindings by cyclosporine
63. Prolactin as a modulator of lymphocyte responsiveness provides a possible mechanism of action for cyclosporine
64. Immunomodulation by hormones—an area of growing importance
65. Correlation study between prolactin and androgens in male patients with systemic lupus erythematosus
66. Systemic lupus erythematosus—survival patterns: Experience with 609 patients
67. Prognostic factors in lupus nephritis
68. Sex differences in childhood lupus nephritis
69. Lupus nephritis in males and females
70. A multicenter study of outcome in systemic lupus erythematosus: II. Causes of death
71. Hemolytic anemia and thrombocytopenic purpura: Two related subsets of lupus erythematosus
72. Systemic lupus erythematosus: A review of clinico-laboratory features and immunogenetic markers in 150 patients with emphasis on demographic subsets
73. Familial systemic lupus erythematosus
74. Family studies in systemic lupus erythe-matosus: I. Prenatal factors
75. The sex of siblings of men with connective tissue diseases
76. Familial systemic lupus erythematosus in males
77. Familial lupus: Family studies of HLA and serologic findings
78. Pulmonary nocardiosis occurrence in men with systemic lupus erythematosus
79. Slowly sedimenting, mercaptoethanol-resistant antinuclear factors related antigenically to M immunoglobulins (m-globulins) in patients with systemic lupus erythematosus
80. Naturally occurring low molecular weight IgM in patients with rheumatoid arthritis, systemic lupus erythematosus and macroglobulinemia
81. The immunoglobulin class of anti-DNA antibodies: detection by fluorometric immunoassay: Clinical and pathological correlations in SLE
82. Male lupus: Clinical and serological features, 7S IgM anti-DNA antibody, and Fc receptor specific clearance
83. Increased 16-hydroxylation of estradiol in systemic lupus erythematosus